Member-only story
How a Psilocybin Study on AIDS Survivors May Solve a Big Problem with Psychedelic Therapy
A recent study paves the way for increased scalability of psychedelic medicine, which is typically costly and time-intensive.
A recent psilocybin study has found that psychedelic psychotherapy may provide mental relief for long term AIDS survivors. The study shows that a new group of people — AIDS survivors with a variety of mental health issues — may benefit from psychedelic therapy.
However, the study also utilized a new application of psychedelic therapy in modern clinical science. This application may solve one of the main issues that is plaguing the field of psychedelics, and further the development of psychedelic medicine.
Small Samples are a Big Problem
Psychedelics are undoubtedly set to change the way the West approaches mental health. Their effectiveness in combatting a panoply of mental disorders is being shown time and time again. Yet, despite these promising results, researchers are crying out for larger sample sizes in psychedelic studies.
Consider the largest and most recent study of psilocybin for depression. 59 participants made up the sample, which was deemed a huge leap…
